| View |
|
DR-XY41317
|
Paracetamol
|
Cortalgesic Xtra
|
1g Sustained Release Tablet
|
Tablet
|
NON OPIOD ANALGESIC / ANTIPYRETIC
|
Lincoln Pharmaceuticals Ltd.
|
India
|
Renewal
|
31 May 2022
|
15 October 2027
|
| View |
|
DR-XY41318
|
Phenytoin Sodium
|
None
|
50mg/mL
|
Solution For Injection
|
Antiepileptic (Hydantoin derivative)
|
Hameln Pharmaceuticals GmbH
|
Germany
|
Automatic Renewal
|
10 November 2022
|
18 October 2027
|
| View |
|
DR-XY41323
|
Hydroxyzine Hydrochloride
|
None
|
10 mg
|
Film-Coated Tablet
|
Anxiolytic
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
18 January 2022
|
18 October 2026
|
| View |
|
DR-XY41327
|
Levedopa + Carbidopa
|
Sinedin
|
250 mg/25 mg
|
Tablet
|
Analgesic / Antipyretic / Muscle Relaxant
|
Sydenham Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
08 July 2022
|
20 November 2027
|
| View |
|
DR-XY41328
|
Hyoscine N-Butylbromide
|
Spacine
|
10 mg
|
Sugar Coated Tablet
|
ANTICHOLINERGIC
|
Geofman Pharmaceuticals
|
Pakistan
|
Automatic Renewal
|
13 July 2022
|
18 October 2027
|
| View |
|
DR-XY41332
|
Adenosine
|
Cardiosine
|
3 mg/mL
|
Solution for Injection (IV)
|
Cardiac Therapy (Other Cardiac Preparation)
|
Swiss Parenterals Ltd.
|
India
|
Renewal
|
16 August 2022
|
18 October 2027
|
| View |
|
DR-XY41338
|
5% Dextrose in Lactated Ringer'S
|
None
|
Each 100 mL contains 5 g Dextrose Monohydrate, 600 mg Sodium Chloride, 310 mg Sodium Lactate, Anhydrous, 30 mg Potassium Chloride, 20 mg Calcium Chloride, Dihydrate & 30 mg Sodium Metabisulfite
|
Solution For IV Infusion
|
-
|
Euro-Med Laboratories Phil., Inc.
|
Philippines
|
-
|
29 July 2020
|
30 September 2025
|
| View |
|
DR-XY41342
|
Cholecalciferol
|
Fern D
|
|
Softgel Capsule
|
Vitamin
|
Hizon Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
20 June 2022
|
30 October 2027
|
| View |
|
DR-XY41346
|
Cefixime (as Trihydrate)
|
Umexim-200
|
200 mg
|
Capsule
|
Antibacterial (Cephalosporin)
|
Umedica Laboratories Pvt. Ltd.
|
India
|
Renewal
|
05 August 2022
|
30 October 2027
|
| View |
|
DR-XY41351
|
Trimetazidine Hydrochloride
|
Angivent Od
|
60 mg
|
Sustained-Release Capsule
|
-
|
Inventia Healthcare Limited
|
India
|
Initial (from monitored Release) (Variation)
|
06 June 2023
|
06 June 2028
|
| View |
|
DR-XY41353
|
Iohexol
|
Omnihexol
|
647 mg/mL (equivalent to 300 mg Iodine)
|
Solution For Injection
|
Non-ionic Radiocontrast Media
|
Korea United Pharma. Inc.
|
Korea
|
Initial (Variation)
|
23 June 2022
|
23 October 2027
|
| View |
|
DR-XY41354
|
Iohexol
|
Omnihexol
|
647 mg/mL (300mgI)
|
Solution for Injection
|
Non-ionic Radiocontrast Media
|
Korea United Pharm Inc.
|
Korea
|
Renewal
|
14 June 2022
|
23 October 2027
|
| View |
|
DR-XY41355
|
Rifampicin/ Ethambutol/ Isoniazid
|
None
|
150mg/275mg/75mg
|
Tablet
|
Antituberculosis
|
Lloyd Laboratores, Inc.
|
Philippines
|
Renewal
|
18 April 2022
|
28 September 2027
|
| View |
|
DR-XY41359
|
Diphenhydramine (As Hydrochloride)
|
Dilamine
|
10 mg/ mL
|
Solution For Injection
|
Antihistamines
|
Swiss Parenterals Pvt. Ltd.
|
India
|
Automatic Renewal
|
05 September 2022
|
25 October 2027
|
| View |
|
DR-XY41360
|
Dextrose 5% In Water
|
None
|
5% (5g/100mL)
|
Solution For Intravenous Infusion
|
-
|
General Hospital Products Public Co. Ltd.
|
Thailand
|
Automatic Renewal
|
24 July 2020
|
25 October 2025
|
| View |
DR-XY41362_PI_01.pdf
|
DR-XY41362
|
Agomelatine
|
Valdoxan
|
25 mg
|
Film-Coated Tablet
|
-
|
Les Laboratoires Servier Industrie
|
France
|
Initial (Variation)
|
10 March 2023
|
10 March 2028
|
| View |
|
DR-XY41363
|
5% Dextrose Lactated Ringer'S Solution
|
None
|
|
Solution For I.V. Infusion
|
-
|
General Hospital Products Public Co. Ltd.
|
Thailand
|
-
|
24 July 2020
|
06 November 2025
|
| View |
|
DR-XY41364
|
Clopidogrel (As Bisulfate) + Aspirin
|
Coplavix
|
75mg/100mg
|
Film Coated Tablet
|
Antithrombotic Agent
|
Sanofi Winthrop Industrie
|
France
|
Automatic Renewal
|
12 October 2022
|
05 November 2027
|
| View |
|
DR-XY41365
|
Balanced Multiple Maintenance Solution With 5% Dextrose (For Adult)
|
Endusol-M
|
|
Solution For Intravenous Infusion
|
Rehydration Solutions
|
Shanxi Nuocheng Pharm'l Co., Ltd.
|
China
|
Automatic Renewal
|
13 October 2022
|
08 November 2027
|
| View |
|
DR-XY41368
|
Atracurium Besilate
|
Atra-Cure
|
10 mg/mL (25 mg/2.5 mL)
|
Solution For Injection (Iv)
|
Muscle relaxant, peripherally acting agent
|
Myungmoon Pharmaceutical Co., Ltd.
|
Korea
|
Initial (Variation)
|
26 July 2023
|
26 July 2028
|